Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 9;331(14):1227-1228.
doi: 10.1001/jama.2024.2511.

Diagnosis and Management of Myotonic Dystrophy Type 1

Julia Hartman  1 , Tejal Patki  1 , Nicholas E Johnson  1
Affiliations

Diagnosis and Management of Myotonic Dystrophy Type 1

Julia Hartman et al. JAMA. .
No abstract available

Plain language summary

This JAMA Insights discusses the signs and symptoms, diagnosis, and treatment of myotonic dystrophy type 1.

PubMed Disclaimer

References

    1. Johnson NE, Butterfield RJ, Mayne K, et al. Population-based prevalence of myotonic dystrophy type 1 using genetic analysis of statewide blood screening program. Neurology. 2021;96(7):e1045–e1053. doi:10.1212/WNL.0000000000011425 - DOI - PMC - PubMed
    1. Liao Q, Zhang Y, He J, Huang K. Global prevalence of myotonic dystrophy. Neuroepidemiology. 2022;56(3):163–173. doi:10.1159/000524734 - DOI - PubMed
    1. Hilbert JE, Ashizawa T, Day JW, et al. Diagnostic odyssey of patients with myotonic dystrophy. J Neurol. 2013;260(10):2497–2504. doi:10.1007/s00415-013-6993-0 - DOI - PMC - PubMed
    1. Mathieu J, Allard P, Potvin L, Prévost C, Bégin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology. 1999;52(8):1658–1662. doi:10.1212/WNL.52.8.1658 - DOI - PubMed
    1. Ashizawa T, Gagnon C, Groh WJ, et al. Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurol Clin Pract. 2018;8(6):507–520. doi:10.1212/CPJ.0000000000000531 - DOI - PMC - PubMed